MiNK Therapeutics, Inc.
149 Fifth Avenue, Suite 500
New York, NY 10010
October 12, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Dillon Hagius
Re: MiNK Therapeutics, Inc.
Registration Statement on Form S-1 (File No. 333-259503)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MiNK Therapeutics, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date for the registration statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 14, 2021, or as soon as possible thereafter. The Company hereby authorizes Zachary Blume of Ropes & Gray LLP, counsel to the Company, to orally modify or withdraw this request for acceleration.
Please call Zachary Blume of Ropes & Gray LLP, counsel to the Company, at (617) 951-7663, as soon as the registration statement has been declared effective.
[Signature page follows]
| Very truly yours, | ||
| MINK THERAPEUTICS, INC. | ||
| By: | /s/ Jennifer S. Buell | |
| Name: | Jennifer S. Buell | |
| Title: | President and Chief Executive Officer | |
[Signature Page to Acceleration Request]
